Book contents
- Medication-Resistant Epilepsy
- Medication-Resistant Epilepsy
- Copyright page
- Dedication
- Contents
- Contributors
- Chapter 1 The Natural History of Epilepsy
- Chapter 2 Challenges in Identifying Medication-Resistant Epilepsy
- Chapter 3 International League Against Epilepsy’s Definition of Medication-Resistant Epilepsy
- Chapter 4 The Economic Impact of Medication-Resistant Epilepsy
- Chapter 5 Social Consequences of Medication-Resistant Epilepsy
- Chapter 6 Mortality and Morbidity of Medication-Resistant Epilepsy
- Chapter 7 Models for Medication-Resistant Epilepsy
- Chapter 8 Neurobiology of Medication-Resistant Epilepsy
- Chapter 9 Genetic Causes of Medication-Resistant Epilepsy
- Chapter 10 Malformations of Cortical Development as Causes of Medication-Resistant Epilepsy
- Chapter 11 Hippocampal Sclerosis as a Cause of Medication-Resistant Epilepsy
- Chapter 12 Autoimmune Causes of Medication-Resistant Epilepsy
- Chapter 13 Medication-Resistant Epilepsy Syndromes in Children
- Chapter 14 Medication-Resistant Epilepsy in Adults
- Chapter 15 Approach to the Treatment of Medication-Resistant Epilepsy
- Chapter 16 Pharmacotherapy for Medication-Resistant Epilepsy
- Chapter 17 Reproductive Health for Women with Medication-Resistant Epilepsy
- Chapter 18 Resective Surgery for Medication-Resistant Epilepsy
- Chapter 19 Ablative Surgery for Medication-Resistant Epilepsy
- Chapter 20 Stimulation Treatment for Medication-Resistant Epilepsy
- Chapter 21 Diet Therapy for Medication-Resistant Epilepsy
- Chapter 22 Botanical Treatments for Medication-Resistant Epilepsy
- Chapter 23 Psychiatric Comorbidities in Medication-Resistant Epilepsy
- Index
- References
Chapter 22 - Botanical Treatments for Medication-Resistant Epilepsy
Published online by Cambridge University Press: 20 August 2020
- Medication-Resistant Epilepsy
- Medication-Resistant Epilepsy
- Copyright page
- Dedication
- Contents
- Contributors
- Chapter 1 The Natural History of Epilepsy
- Chapter 2 Challenges in Identifying Medication-Resistant Epilepsy
- Chapter 3 International League Against Epilepsy’s Definition of Medication-Resistant Epilepsy
- Chapter 4 The Economic Impact of Medication-Resistant Epilepsy
- Chapter 5 Social Consequences of Medication-Resistant Epilepsy
- Chapter 6 Mortality and Morbidity of Medication-Resistant Epilepsy
- Chapter 7 Models for Medication-Resistant Epilepsy
- Chapter 8 Neurobiology of Medication-Resistant Epilepsy
- Chapter 9 Genetic Causes of Medication-Resistant Epilepsy
- Chapter 10 Malformations of Cortical Development as Causes of Medication-Resistant Epilepsy
- Chapter 11 Hippocampal Sclerosis as a Cause of Medication-Resistant Epilepsy
- Chapter 12 Autoimmune Causes of Medication-Resistant Epilepsy
- Chapter 13 Medication-Resistant Epilepsy Syndromes in Children
- Chapter 14 Medication-Resistant Epilepsy in Adults
- Chapter 15 Approach to the Treatment of Medication-Resistant Epilepsy
- Chapter 16 Pharmacotherapy for Medication-Resistant Epilepsy
- Chapter 17 Reproductive Health for Women with Medication-Resistant Epilepsy
- Chapter 18 Resective Surgery for Medication-Resistant Epilepsy
- Chapter 19 Ablative Surgery for Medication-Resistant Epilepsy
- Chapter 20 Stimulation Treatment for Medication-Resistant Epilepsy
- Chapter 21 Diet Therapy for Medication-Resistant Epilepsy
- Chapter 22 Botanical Treatments for Medication-Resistant Epilepsy
- Chapter 23 Psychiatric Comorbidities in Medication-Resistant Epilepsy
- Index
- References
Summary
Botanical treatments have been used by persons with epilepsy, especially for convulsive seizures, dating from 6000 BC in India [1], from 3000 BC in China and in Peru, and for centuries in Africa and South America. In traditional Western medicine, botanical treatments were widely used to treat seizures before the advent of compounds such as bromide and phenobarbital. For instance, Gowers documented his use of Cannabis indica (see also section on Cannabis and its Derivatives) and digitalis, the latter derived from the Foxglove plant (Digitalis purpurea) [2].
- Type
- Chapter
- Information
- Medication-Resistant EpilepsyDiagnosis and Treatment, pp. 248 - 255Publisher: Cambridge University PressPrint publication year: 2020